) for setting up experimental procedures. Contributors EC, CS, ERV and TFB wrote the manuscript. EC, CS and ML designed experiments. EC and MAO performed experiments, INSERM UMR_S1110 ,
, and benefits from funding from the state managed by the French National Research Agency as part of the Investments for the future programme. EC and ML were supported by a fellowship of the French Ministry for Research and Education (MESR). TFB acknowledges funding by the European Union (ERC-AdG-2014 HEPCIR, EU2020 HEPCAR, EU-Interreg IV-Rhin Supérieur-FEDER-Hepato-Regio-Net) and ARC-IHU (TheraHCC programme) (ARC IHU201301187), CS acknowledges funding by the Agence Nationale de Recherches sur le SIDA (ANRS) (2010-307/2011-415) and the Initiative d'excellence
, Ethics approval Strasbourg University Ethical Committee (Approval # CPP, pp.10-17
, Provenance and peer review Not commissioned; externally peer reviewed
Epidemiology of hepatitis C virus infection, World J Gastroenterol, vol.13, pp.2436-2477, 2007. ,
Curing chronic hepatitis C-the arc of a medical triumph, N Engl J Med, vol.370, pp.1576-1584, 2014. ,
A prophylactic hepatitis C virus vaccine: a distant peak still worth climbing, J Hepatol, vol.61, pp.34-44, 2014. ,
Hepatitis C virus, cholesterol and lipoproteins-impact for the viral life cycle and pathogenesis of liver disease, Viruses, vol.5, pp.1292-324, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-00850889
Characterization of low-and very-low-density hepatitis C virus RNA-containing particles, J Virol, vol.76, pp.6919-6947, 2002. ,
Biochemical and morphological properties of hepatitis C virus particles and determination of their lipidome, J Biol Chem, vol.286, pp.3018-3050, 2011. ,
Human apolipoprotein E is required for infectivity and production of hepatitis C virus in cell culture, J Virol, vol.81, pp.13783-93, 2007. ,
Hepatitis C virus attachment mediated by apolipoprotein E binding to cell surface heparan sulfate, J Virol, vol.86, pp.7256-67, 2012. ,
Apolipoprotein E interacts with hepatitis C virus nonstructural protein 5A and determines assembly of infectious particles, Hepatology, vol.51, pp.43-53, 2010. ,
URL : https://hal.archives-ouvertes.fr/inserm-00705655
Apolipoprotein E likely contributes to a maturation step of infectious hepatitis C virus particles and interacts with viral envelope glycoproteins, J Virol, vol.88, pp.12422-12459, 2014. ,
Apolipoprotein E structure: insights into function, Trends Biochem Sci, vol.31, pp.445-54, 2006. ,
Impact of apoE genotype on oxidative stress, inflammation and disease risk, Mol Nutr Food Res, vol.52, pp.131-176, 2008. ,
Apoprotein E as a lipid transport and signaling protein in the blood, liver, and artery wall, J Lipid Res, vol.50, pp.156-161, 2009. ,
Apolipoprotein E: far more than a lipid transport protein, Annu Rev Genomics Hum Genet, vol.1, pp.507-544, 2000. ,
Apolipoprotein-mediated removal of cellular cholesterol and phospholipids, J Lipid Res, vol.37, pp.2473-91, 1996. ,
Lipidation of apolipoprotein E influences its isoform-specific interaction with Alzheimer's amyloid beta peptides, Biochem J, vol.348, issue.2, pp.359-65, 2000. ,
Apolipoprotein E4 is deficient in inducing macrophage ABCA1 expression and stimulating the Sp1 signaling pathway, PLoS ONE, vol.7, p.44430, 2012. ,
Inhibition of hepatitis C virus infection by anti-claudin-1 antibodies is mediated by neutralization of E2-CD81-Claudin-1 associations, Hepatology, vol.51, pp.1144-57, 2010. ,
URL : https://hal.archives-ouvertes.fr/inserm-00705657
Hepatitis C virus RNA replication is resistant to tumour necrosis factor-alpha, J Gen Virol, vol.84, pp.1253-1262, 2003. ,
RACK1 controls IRES-mediated translation of viruses, Cell, vol.159, pp.1086-95, 2014. ,
Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses, J Virol, vol.80, pp.5308-5328, 2006. ,
Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras, Proc Natl Acad Sci, vol.103, pp.7408-7421, 2006. ,
Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81, Hepatology, vol.46, pp.1722-1753, 2007. ,
URL : https://hal.archives-ouvertes.fr/inserm-00395706
Production of infectious hepatitis C virus in tissue culture from a cloned viral genome, Nat Med, vol.11, pp.791-797, 2005. ,
Real-time detection system for quantification of hepatitis C virus genome, Gastroenterology, vol.116, pp.636-678, 1999. ,
EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy, Nat Med, vol.17, pp.589-95, 2011. ,
URL : https://hal.archives-ouvertes.fr/inserm-00705829
Lipoprotein separation in a novel iodixanol density gradient, for composition, density, and phenotype analysis, J Lipid Res, vol.49, pp.1364-71, 2008. ,
Intrahepatic role of exchangeable apolipoproteins in lipoprotein assembly and secretion, Arterioscler Thromb Vasc Biol, vol.32, pp.1073-1081, 2012. ,
Sterol efflux mediated by endogenous macrophage ApoE expression is independent of ABCA1, Arterioscler Thromb Vasc Biol, vol.21, pp.2019-2044, 2001. ,
Lipid free apolipoprotein E binds to the class B Type I scavenger receptor I (SR-BI) and enhances cholesteryl ester uptake from lipoproteins, J Biol Chem, vol.277, pp.36092-36101, 2002. ,
A novel function of apolipoprotein E: upregulation of ATP-binding cassette transporter A1 expression, PLoS ONE, vol.6, p.21453, 2011. ,
Determination of the lower threshold of apolipoprotein E resulting in remnant lipoprotein clearance, J Lipid Res, vol.40, pp.1529-1567, 1999. ,
Low levels of extrahepatic nonmacrophage ApoE inhibit atherosclerosis without correcting hypercholesterolemia in ApoE-deficient mice, Arterioscler Thromb Vasc Biol, vol.20, pp.1939-1984, 2000. ,
Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding, Hepatology, vol.56, pp.484-91, 2012. ,
Hepatic heparan sulfate proteoglycans and endocytic clearance of triglyceride-rich lipoproteins, Prog Mol Biol Transl Sci, vol.93, pp.213-246, 2010. ,
Apolipoprotein E recycling implications for dyslipidemia and atherosclerosis, Arterioscler Thromb Vasc Biol, vol.26, pp.442-450, 2006. ,
Intracellular trafficking of recycling apolipoprotein E in Chinese hamster ovary cells, J Lipid Res, vol.47, pp.1176-86, 2006. ,
Differential regulation of amyloid-? endocytic trafficking and lysosomal degradation by apolipoprotein E isoforms, J Biol Chem, vol.287, pp.44593-601, 2012. ,
Acid wash in determining cellular uptake of Fab/cell-permeating peptide conjugates, Biopolymers, vol.88, pp.98-107, 2007. ,
Hepatitis C virus RNA replication occurs on a detergent-resistant membrane that cofractionates with caveolin-2, J Virol, vol.77, pp.4160-4168, 2003. ,
The influence of cholesterol and lipid metabolism on host cell structure and hepatitis C virus replication, Biochem Cell Biol, vol.84, pp.67-79, 2006. ,
ABC transporters, atherosclerosis and inflammation, Atherosclerosis, vol.211, pp.361-70, 2010. ,
Structure-function properties of the apoE-dependent COX-2 pathway in vascular smooth muscle cells, Atherosclerosis, vol.196, pp.201-210, 2008. ,
Apolipoprotein E-dependent cholesterol efflux from macrophages: kinetic study and divergent mechanisms for endogenous versus exogenous apolipoprotein E, J Lipid Res, vol.40, pp.1618-1644, 1999. ,
Endogenous apolipoprotein E modulates cholesterol efflux and cholesteryl ester hydrolysis mediated by high-density lipoprotein-3 and lipid-free apolipoproteins in mouse peritoneal macrophages, J Mol Med, vol.78, pp.217-244, 2000. ,
A pathway-dependent on ApoE, ApoAI, and ABCA1 determines formation of buoyant high-density lipoprotein by macrophage foam cells, Arterioscler Thromb Vasc Biol, vol.27, pp.1123-1154, 2007. ,
Cholesterol efflux is differentially regulated in neurons and astrocytes: implications for brain cholesterol homeostasis, Biochim Biophys Acta, vol.1831, pp.263-75, 2013. ,
Novel Apo E-Derived ABCA1 Agonist Peptide (CS-6253) Promotes Reverse Cholesterol Transport and Induces Formation of pre?-1 HDL In Vitro, PLoS ONE, vol.10, p.131997, 2015. ,
ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation, Cell Metab, vol.1, pp.121-152, 2005. ,
The lipidation by hepatocytes of human apolipoprotein A-I occurs by both ABCA1-dependent and -independent pathways, J Biol Chem, vol.278, pp.10119-10146, 2003. ,
LXR-induced redistribution of ABCG1 to plasma membrane in macrophages enhances cholesterol mass efflux to HDL, Arterioscler Thromb Vasc Biol, vol.26, pp.1310-1326, 2006. ,
ApoE suppresses atherosclerosis by reducing lipid accumulation in circulating monocytes and the expression of inflammatory molecules on monocytes and vascular endothelium, Arterioscler Thromb Vasc Biol, vol.32, pp.264-72, 2012. ,
Apolipoprotein E produced by human monocyte-derived macrophages mediates cholesterol efflux that occurs in the absence of added cholesterol acceptors, J Biol Chem, vol.271, pp.28641-28647, 1996. ,